% | Patients switching from SGCs BID to Tablets BID (%) | Patients switching from SGCs BID or QD to Tablets QD (%) |
---|---|---|
Male/Female | 85/15 | 76/24 |
Age: | ||
> 45 years | 46 | 34 |
35–44 years | 41 | 39 |
< 35 years | 13 | 27 |
Duration of antiviral therapy | ||
≥ 5 years | 59 | 41 |
1–5 years | 31 | 49 |
< 1 year | 10 | 10 |
Duration of LPV/r therapy | ||
SGC > 1 year | 82 | 80 |
Tablet < 3 months | 89 | 81 |